Immunexpress Inc.
We are pioneering the technology that analyzes the immune system to rapidly detect sepsis.
Seattle, United States
20 employees
Series Unknown
Biotechnology, Health Care +1
General Information
Get notified when Immunexpress Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Immunexpress Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Immunexpress Inc.
Taxonomy: Molecular Diagnostics, Sepsis, Clinical Assays, Immune System Analysis, Genomic Biomarkers, Proteomic Biomarkers, Diagnostic Assays, Point-of-Care, Early Detection, Therapy Monitoring, Medical Innovation, Immunology
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture - Series Unknown | •••••• | - | 03 Oct 2019 | |
| Debt Financing | •••••• | - | 03 Apr 2015 | |
| Series B | •••••• | - | 05 May 2014 | |
| Venture - Series Unknown | •••••• | - | 05 Mar 2014 | |
| Venture - Series Unknown | •••••• | - | 19 Jun 2012 |
Immunexpress Inc. Alternatives & Competitors
Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years.
Harnessing the predictive power of blood-borne miRNAs
Pioneer of human in vitro systems for toxicology and compound safety screening to improve human heal...
FAQ About Immunexpress Inc.
Don't just browse. Track.
Signal Tracker monitors Immunexpress Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
